H. Lundbeck A/S (HLUBF)

$4.97 +0.38 (8.28%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 200
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 100%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company offers Abilify Maintena/ Abilify Asimtufii for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Rexulti/Rxulti to treat major depressive disorder and schizophrenia; Vyepti for migraine prevention; and Cipralex/Lexapro for de...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 45 36 30 13 11
Fax: 45 36 30 19 40
Address:
Ottiliavej 9, Valby, Denmark
Quantumup
Quantumup Sep. 8 at 11:14 AM
BTIG🏁 $DRUG Buy/$72. LBPH - $HLUBF/ $HLBBF $UCBJY $PRAX BTIG said in its initiation report: Bright Minds Biosciences ( $DRUG, Buy, $72 PT) is developing a very specific 5-HT2C agonist for epilepsies that is widely viewed as Longboard-like, but with key points of differentiation. BTIG added:
0 · Reply
Quantumup
Quantumup Aug. 26 at 8:05 PM
BTIG reit'd $TBPH Buy-$25/said it conts2view CYPRESS as sig derisked by preceding P3s— $TBPH utilized an external enrollment cmte =g same clinical neuro's for both Study 0170/CYPRESS, supporting pot for +VE readthru between the two trials. $ATHE $HLUBF $HLBBF $GSK AZN BTIG said:
0 · Reply
Quantumup
Quantumup Aug. 20 at 2:03 PM
H.C. Wainwright reiterated $DRUG Buy/$85. LBPH - $HLUBF/ $HLBBF $PRAX $JAZZ UCBJY UCBJF SNDX AVXL PHVS H.C. Wainwright said in its note:
0 · Reply
macroaxis
macroaxis Apr. 29 at 3:32 AM
$HLUBF - trending. https://www.macroaxis.com/target-price/HLUBF #stocks #earnings
0 · Reply
Latest News on HLUBF
No data available.
Quantumup
Quantumup Sep. 8 at 11:14 AM
BTIG🏁 $DRUG Buy/$72. LBPH - $HLUBF/ $HLBBF $UCBJY $PRAX BTIG said in its initiation report: Bright Minds Biosciences ( $DRUG, Buy, $72 PT) is developing a very specific 5-HT2C agonist for epilepsies that is widely viewed as Longboard-like, but with key points of differentiation. BTIG added:
0 · Reply
Quantumup
Quantumup Aug. 26 at 8:05 PM
BTIG reit'd $TBPH Buy-$25/said it conts2view CYPRESS as sig derisked by preceding P3s— $TBPH utilized an external enrollment cmte =g same clinical neuro's for both Study 0170/CYPRESS, supporting pot for +VE readthru between the two trials. $ATHE $HLUBF $HLBBF $GSK AZN BTIG said:
0 · Reply
Quantumup
Quantumup Aug. 20 at 2:03 PM
H.C. Wainwright reiterated $DRUG Buy/$85. LBPH - $HLUBF/ $HLBBF $PRAX $JAZZ UCBJY UCBJF SNDX AVXL PHVS H.C. Wainwright said in its note:
0 · Reply
macroaxis
macroaxis Apr. 29 at 3:32 AM
$HLUBF - trending. https://www.macroaxis.com/target-price/HLUBF #stocks #earnings
0 · Reply